Deutsch
A A A
DE
Bereichsnavigation

Previous
Ad-hoc-News | 05/24/2009

RHÖN-KLINIKUM AG: Planned capital increase in the second half of the year utilising the authorised capital pursuant to Section 4 (2) of the Company\'s Articles of Association

RHÖN-KLINIKUM AG: Planned capital increase in the second half of the year utilising the authorised capital pursuant to Section 4 (2) of the Company's Articles of Association


RHÖN-KLINIKUM AG / Capital Increase

Release of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.



RHÖN-KLINIKUM AG hereby informs that the Board of Management and the
Supervisory Board of RHÖN-KLINIKUM AG have adopted today, Sunday, 24 May
2009, the following resolution:

The Board of Management is preparing a capital increase to meet the
impending privatisation wave from 2010 onwards. The capital increase will
be carried out in the second half of the year utilising the authorised
capital pursuant to Section 4 (2) of the Company's Articles of Association.
By raising a substantial amount, of approximately EUR 500 million, the
basis will be created for further growth. The precise terms will be decided
shortly before the commencement of the subscription period, and will
reflect the strength of our business model. For this purpose, the Board of
Management and the Supervisory Board will then adopt a second resolution.

Explanation:

The Management and the Supervisory Board are convinced of being able to
create secure delivery of high-quality medical care provision with its
long-proven and future-oriented care and business model. They are
responding to the expected rationing in medical care services by
guaranteeing high-quality medical services through rationalisation. This is
how the Company intends to stay at the forefront of the movement and to
invite shareholders to participate in this development.

Rationalisation expertise and innovative strength are the foundation of the
Company's growth. The network of hospitals secures and strengthens the high
quality of medical care through the modernisation of distressed hospitals
and the efficient integration of outpatient and inpatient care. Its big
advantage is the capability of continuously investing in the performance
and quality of modern medical care delivery and of optimally integrating
core medical processes in the outpatient and inpatient areas.

Rationalisation instead of rationing - that is the guiding principle of
RHÖN KLINIKUM AG in medical care. This guiding principle has convinced our
shareholders for 20 years and our patients for over 30 years. The Company
operates hospitals and medical care centres (MVZs) in which 1.6 million
people put their trust in 2008. Since the IPO in 1989, it has enjoyed
uninterrupted growth and in 2008 reached new heights, generating revenues
of EUR 2.1 billion, net profit of EUR 122.6 million, and employing over
33,000 persons.

Starting from its existing 37 sites, the company in the medium term is
seeking to provide general-coverage high-quality medical care that everyone
can afford: any patient is to be able to reach a healthcare facility of the
hospital network within 1.5 to two hours or less. This is to lay the
foundation for covering 8 per cent of total medical care provision.

In the face of a recession with a decline in gross domestic product of
roughly 6 per cent, municipalities and federal states will no longer be
able to meet their medical care provision mandate to a sufficient extent.
That is why an anticyclical corporate strategy in the healthcare sector
will become all the more important for securing this care provision
mandate. It was for this reason that during the last recession in 2002/2003
the state transferred to us nearly 20 hospitals so that investment,
employment and healthcare provision could be ensured and a rationing of
medical care averted. This was the starting point for the strong revenue
and earnings performance seen over the past years.

With the capital increase we are offering our shareholders the possibility
of participating in the continuation of this development and of acquiring a
stake in the Company's growth concept.


Dr. Erik Hamann
Member of the Board of Management for Financing, IR, Controlling
Tel. +49 9771 65-1351 Fax: +49 9771 991736
E-mail: vfire@rhoen-klinikum-ag.com



24.05.2009 Financial News transmitted by DGAP



Language: English
Issuer: RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a.d.Saale
Deutschland
Phone: +49 (0)9771 - 65-0
Fax: +49 (0)9771 - 97 467
E-mail: rka@rhoen-klinikum-ag.com
Internet: www.rhoen-klinikum-ag.com
ISIN: DE0007042301
WKN: 704230
Indices: MDAX
Listed: Regulierter Markt in Frankfurt (Prime Standard), München;
Freiverkehr in Berlin, Düsseldorf, Hamburg, Stuttgart

End of News DGAP News-Service